Jae B. Kim - 13 Mar 2024 Form 3 Insider Report for Design Therapeutics, Inc. (DSGN)

Role: Chief Medical Officer
Signature: /s/ Mustapha Parekh, Attorney-in-Fact
Issuer symbol: DSGN
Transactions as of: 13 Mar 2024
Net transactions value: $0
Form type: 3
Filing time: 20 Mar 2024, 19:57:52 UTC
Next filing: 24 Oct 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DSGN	Common Stock						4,756	13 Mar 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	DSGN	Stock Option (right to buy)							13 Mar 2024	Common Stock	315,000	$12.77	Direct	F1
holding	DSGN	Stock Option (right to buy)							13 Mar 2024	Common Stock	115,000	$7.97	Direct	F2
holding	DSGN	Stock Option (right to buy)							13 Mar 2024	Common Stock	175,000	$2.54	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option will vest as follows: 25% of the shares vested on January 24, 2023, and the balance will vest in equal monthly installments thereafter over a three year period.
F2	The shares subject to the option will vest as follows: 20% of the shares vested on February 1, 2024, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months.
F3	The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2025, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months.